Why are we asking you to sign in? Find out more here
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy .
Why are we asking you to sign in? Find out more here
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy .
Doping violation due to marijuana use leaves Cynthia Calvillo facing suspension
THREE WEEKS SINCE she suffered the first defeat of her career, Cynthia Calvillo has been hit with another unwelcome development.
The 30-year-old Californian (6-1), who was beaten by Carla Esparza via unanimous decision on 30 December, failed an in-competition drug test for Carboxy-Tetrahydrocannabinol [THC] in relation to the UFC 219 bout in Las Vegas.
Carboxy-Tetrahydrocannabinol is “a metabolite of marijuana and/or hashish”, according to a UFC statement. Calvillo has been flagged by the United States Anti-Doping Agency [USADA] for being “above the decision limit of 180 ng/mL” for the substance.
In order to determine the sanctions that will subsequently be handed down, Calvillo will now be subjected to an adjudication process which will be carried out by both USADA and the Nevada Athletic Commission.
The UFC’s statement on the matter reads:
In April of last year, UFC middleweight Kelvin Gastelum was handed a three-month suspension and had his win against Vitor Belfort overturned to a ‘no contest’ after he failed a test as a result of marijuana use.
Calvillo made her UFC debut in March 2017 and embarked on a 3-0 run with the promotion prior to her defeat to Esparza. She is currently ranked eighth in the women’s 115-pound division.
Dana White reveals UFC 223 bout for Ferguson and Nurmagomedov
UFC planning to strip McGregor of title in favour of Ferguson-Khabib bout
To embed this post, copy the code below on your site
Cynthia Calvillo MMA UFC